AARTIPHARMBSEAarti Pharmalabs LtdMinimalNeutral
Announced Wed, 27 May · 12:23 IST

Newspaper Publication of Financial Results

AARTIPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.9%1-day move
₹694.65
prior close
₹662.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.0+0.0-0.2-6.9-7.6-8.4-10.5-7.6-12.5-5.1-2.4-1.7
Up moveDown movePending
AI summary

Aarti Pharmalabs Ltd has published its standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026, in compliance with SEBI Listing Regulations. The results were published in Financial Express (English) and Loksatta-Jansatta (Gujarati) on Wednesday, May 27, 2026. The company submitted this filing to BSE (Scrip Code: 543748) and NSE (Symbol: AARTIPHARM) under Regulations 30 and 47 of the SEBI Listing Regulations, which mandate public disclosure of financial results through newspapers. The actual numerical figures from the results are not directly readable from the enclosed newspaper clippings in this filing. The filing was signed by Jeevan Mondkar, Company Secretary and Legal Head.

Likely market impact

This is a routine regulatory compliance filing confirming that audited annual and quarterly results have been made public through newspapers as required by SEBI. The actual financial performance data and any associated market reaction would depend on the numbers disclosed in the newspaper publications.